RB1 and glioblastoma: These results were also confirmed in EdU assays, where the percentages of EdU-positive cells were significantly reduced in the U251 and A172 cells treated with 2 and 4 μM RB (Figures 1E,F), indicating that RB significantly inhibited the proliferation of human GBM cells.